Neogenomics (NEO) Cash from Operations Growth (1y) (2011 - 2026)
Neogenomics (NEO) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -101.15% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 64.87% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.77% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 11.89% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -9.63% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 25.34% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 8.80% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 20.42% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -28.11% |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn | 67.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.87% |
| Dec 31, 2025 | -86.30% |
| Sep 30, 2025 | -3.92% |
| Jun 30, 2025 | 46.34% |
| Mar 31, 2025 | 2.27% |
| Dec 31, 2024 | -44.89% |
| Sep 30, 2024 | 268.20% |
| Jun 30, 2024 | 997.42% |
| Mar 31, 2024 | -104.18% |
| Dec 31, 2023 | 582.61% |
| Sep 30, 2023 | 66.22% |
| Jun 30, 2023 | 90.89% |
| Mar 31, 2023 | 56.29% |
| Dec 31, 2022 | 81.37% |
| Sep 30, 2022 | -109.50% |
| Jun 30, 2022 | -1,122.73% |
| Mar 31, 2022 | -1,414.03% |
| Dec 31, 2021 | -430.43% |
| Sep 30, 2021 | -1,576.62% |
| Jun 30, 2021 | -173.86% |